Nov Atias nackt - Galerie mit Fotos und Videos

Novartis to acquire UK-based Myricx Bio for up to $1.5 billion

Novartis to buy Myricx Bio for up to $1.5 billion

Novartis dismisses 322 more staffers based out of US headquarters

Novartis slashes New Jersey workforce again, cutting 322 employees

Novartis to acquire Myricx Bio in up to $1.5bn deal

Novartis isn't done restructuring: Another 322 jobs go in fourth layoff round

Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform

Novartis to Acquire Myricx Bio for Up to $1.5B, Adding Cancer-Fighting ADC Payload Platform

Novartis to acquire ADC developer in a deal worth up to $1.5B

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

Novartis (SWX:NOVN) To Acquire Myricx Bio In $1.5 Billion Oncology Deal

Novartis scoops up UK biotech Myricx in $1.5 billion cancer push

Novartis acquires biotech Myricx Bio to strengthen its oncology pipeline in a $1,1 billion deal.

Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics

Novartis to buy UK biotech Myricx Bio for up to $1.5B

Novartis snaps up UK ADC developer Myricx Bio

Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix

Novartis targets undruggable cancers with $1.9BN Antares Therapeutics deal

Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely

Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis

Scorpion team lands $1.9B Novartis deal with new biotech

Novartis and Antares to develop cancer drugs in a deal worth up to $1.9B

The Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCell

Top Stock Reports for JPMorgan, Novartis & Qualcomm

Novartis brings India's first 'guided missile' therapy for prostate cancer

Genentech, Novartis accused of Xolair kickback scheme in lawsuit

Novartis Canada and SP Quebec Celebrate 16 Years of Partnership Through Annual MS Tri-Challenge Fundraiser

Novartis’ Relax Your Tight End wins Pharma Grand Prix at Cannes Lions

Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease

Novartis to invest more in Chinese mainland, senior executives say